These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37858909)

  • 1. Fractional laser combined with 5-Aminolevulinic acid photodynamic therapy for the treatment of Cutaneous Rosai-Dorfman Disease: A case report.
    Wang H; Wang C; Wang X; Zhang L; Zhang M; Ge L; You Y
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103852. PubMed ID: 37858909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminolevulinic acid photodynamic therapy combined with CO
    Song H; Wang T
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102696. PubMed ID: 34923156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cutaneous Rosai-Dorfman disease with ALA-PDT combined with low-dose oral corticosteroids: A case report.
    Zhou R; Wang T; Li E; Li L
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103914. PubMed ID: 38042238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: A case report.
    Wan M; Ding A; Liu H; Ou J; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101879. PubMed ID: 32562733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of Rosai-Dorfman disease using ALA-PDT.
    Sun L; Shi J; Su Z; Zhang M; Lu Y
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():128-129. PubMed ID: 29197644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease: a systematic review and reappraisal of its treatment and prognosis.
    Dhrif O; Litaiem N; Lahmar W; Fatnassi F; Slouma M; Zeglaoui F
    Arch Dermatol Res; 2024 Jun; 316(7):393. PubMed ID: 38878198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermoscopic follow-up of cutaneous rosai-dorfman: Spontaneous regression.
    Hu C; Cao Y; Yang X; Cao Z; Xu M; Shi L; Wang X
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102263. PubMed ID: 33771755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic elastosis perforans serpiginosa with satisfactory response after 5-ALA photodynamic therapy.
    Alique-García S; Company-Quiroga J; Horcajada-Reales C; Echeverría-García B; Tardío-Dovao JC; Borbujo J
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():55-57. PubMed ID: 29129543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of Intraocular Rosai- Dorfman Disease Following Treatment with Photodynamic Therapy.
    Ward TE; Meirick T; Reiss B; Stacey AW
    Ophthalmic Surg Lasers Imaging Retina; 2021 Oct; 52(10):568-571. PubMed ID: 34661466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid.
    Takeda H; Kaneko T; Harada K; Matsuzaki Y; Nakano H; Hanada K
    Dermatology; 2005; 211(3):264-6. PubMed ID: 16205072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Rosai-Dorfman disease.
    Parrent T; Clark T; Hall D
    Cutis; 2012 Nov; 90(5):237-8. PubMed ID: 23270193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purely Cutaneous Rosai-Dorfman disease (CRDD) co-existed with capillary hemangioma successfully treated with intralesional corticosteroid.
    Asawabenjang W; Jerasutus S; Kattipathanapong P; Janjumratsang P; Tangjaturonrusamee C
    J Med Assoc Thai; 2013 Sep; 96(9):1239-41. PubMed ID: 24164002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.
    Geller S; Busam K; Hamlin PA; Moskowitz AJ; Horwitz SM; Myskowski PL
    J Dermatolog Treat; 2019 Aug; 30(5):503-505. PubMed ID: 30244619
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy.
    Fumerton R; Ball N; Zhou Y
    Cutis; 2011 Jun; 87(6):296-9. PubMed ID: 21838087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing non-ablative fractional photothermolysis prior to ALA-photodynamic therapy in the treatment of acne vulgaris: a case series.
    Qureshi S; Lin JY
    Lasers Med Sci; 2017 Apr; 32(3):729-732. PubMed ID: 27738837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALA-PDT combined with CO
    Chen Y; Wu M; Chen L; Li Z; Zhou Z; Li W; Zhang G
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104299. PubMed ID: 39089478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split-Sided Chest Study of Skin Rejuvenation Comparing Low-Energy, 1,927-nm Thulium Fractional Laser Treatment Prior to Photodynamic Therapy Versus Photodynamic Therapy Alone.
    Croix J; Burge S; Chwalek J; Gmyrek R; Chapas A
    Lasers Surg Med; 2020 Jan; 52(1):53-60. PubMed ID: 31729052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.